Safety and Efficacy of [<sup>177</sup>Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years-Reference-Cited by-同舟云学术

Safety and Efficacy of [¹⁷⁷Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years

Published:2023-06-15 Issue:8 Volume:64 Page:1244-1251
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Tauber Robert,Knorr Karina,Retz Margitta,Rauscher Isabel,Grigorascu Sonia,Hansen Kimberley,D’Alessandria Calogero,Wester Hans-Jürgen,Gschwend Jürgen,Weber Wolfgang,Eiber Matthias,Langbein Thomas

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Prostate cancer in the elderly

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology

4. The prevalence and outcomes of frailty in older cancer patients: a systematic review

5. Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA-based therapeutics for prostate cancer;Expert Opinion on Pharmacotherapy;2024-07-02

2. Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going;Cancer Treatment Reviews;2024-06

3. Systemtherapie des Prostatakarzinoms im hohen Alter;Die Onkologie;2024-01-26